Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences
Wang, Tracy Y , Mi, Xiaojuan, Robinson, Jennifer G. , Roger, Véronique L. , Goldberg, Anne C. , Návar, Ann Marie , Virani, Salim S. , Wilson, Peter W.F. , Peterson, Eric D.

Mayo Clinic

JAMA Cardiology | November 12, 2018 | Volume: 3 | Issue: 12 | Pages: 1192

10.1001/jamacardio.2018.3680 | PMID 30419113 Get It

Author response: Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
Liao, Lili, Langbein, Lauren , Cho, Eun-Ah , Niu, Xiaohua , Jiang, Wei , Zhong, Zhijiu , Jagannathan, Geetha , Dulaimi, Essel, Testa, Joseph R. , Wang, Yuxin , Stark, George R. , Peiper, Stephen, Yang, Haifeng , Liu, Zongzhi Z. , Cai, Weijia , Na, Jie, Cai, Wesley L. , Uzzo, Robert G. , Sun, Jianxin , Xu, Yaomin , Yan, Qin

Mayo Clinic

No container title available | November 12, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.37925.029 Get It

RELATIONSHIPS OF MID-LIFE INFARCT BURDEN WITH LATE-LIFE MILD COGNITIVE IMPAIRMENT AND DEMENTIA: THE ARIC STUDY
Windham, B. Gwen , Griswold, Michael , Wang, W, Knopman, David S. , Gottesman, Rebecca F. , Shibata, Dean , Mosley, Thomas H.

Mayo Clinic

Innovation in Aging | November 10, 2018 | Volume: 2 | Issue: suppl_1 | Pages: 771-771

10.1093/geroni/igy023.2854 Get It

The Reciprocity between Radiotherapy and Cancer Immunotherapy
Wang, Yifan , Liu, Zhi-Gang, Yuan, Hengfeng , Deng, Weiye , Li, Jing , Huang, Yu-Hui , Kim, Betty Y.S. , Story, Michael D. , Jiang, Wen , Huang, Yuhui , Huang, Yuhui , Jiang, Wen , Kim, Betty Y S

Mayo Clinic

Clinical Cancer Research | November 9, 2018 | Volume: 25 | Issue: 6 | Pages: 1709-1717

10.1158/1078-0432.ccr-18-2581 | PMID 30413527 Get It

Abstract The clinical success of immune checkpoint inhibitors in treating metastatic and refractory cancers has generated significant interest in investigating their role in treating locally advanced diseases, thus requiring them to be combined with standard treatments in the hope of producing synergistic antitumor responses. Radiotherapy, in particular, has long been hypothesized to have actions complementary to those of immune checkpoint blockade, and a growing body of evidence indicates that cancer immunotherapy may also have radiosensitizing effects, which would provide unique benefit for locoregional treatments. Recent studies have demonstrated that when immune cells are activated by immunotherapeutics, they can reprogram the tumor microenvironment in ways that may potentially increase the radiosensitivity of the tumor. In this review, we highlight the evidence that supports reciprocal interactions between cancer immunotherapy and radiotherapy, where in addition to the traditional notion that radiation serves to enhance the activation of antitumor immunity, an alternative scenario also exists in which T-cell activation by cancer immunotherapy may sensitize tumors to radiation treatment through mechanisms that include normalization of the tumor vasculature and tissue hypoxia. We describe the empirical observations from preclinical models that support such effects and discuss their implications for future research and trial design.
Nonalcoholic Fatty Liver Disease
Wang, Xiao‐Jing , Malhi, Harmeet

Mayo Clinic

Annals of Internal Medicine | November 6, 2018 | Volume: 169 | Issue: 9 | Pages: ITC65-ITC80

10.7326/aitc201811060 | PMID 30398639 Get It

Obese Patients Benefit, but do not Fare as Well as Nonobese Patients, Following Lumbar Spondylolisthesis Surgery: An Analysis of the Quality Outcomes Database
Chan, Andrew K. , Bisson, Erica F. , Bydon, Mohamad , Glassman, Steven D. , Foley, Kevin T. , Potts, Eric A. , Shaffrey, Christopher I. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S, Kerezoudis, Panagiotis, DiGiorgio, Anthony M. , Haid, Regis W., Mummaneni, Praveen V. , Virk, Michael S, Kerezoudis, Panagiotis

Mayo Clinic

Neurosurgery | November 5, 2018 | Volume: 86 | Issue: 1 | Pages: 80-87

10.1093/neuros/nyy589 | PMID 30541141 Get It

Abstract BACKGROUND Given recent differing findings following 2 randomized clinical trials on degenerative lumbar spondylolisthesis (DLS) surgery, there is a need to better define how subsets of patients fare following surgery. OBJECTIVE To investigate the impact of obesity on patient-reported outcomes (PROs) following DLS surgery. METHODS A total of 12 high-enrolling sites were queried, and we found 797 patients undergoing surgery for grade 1 DLS. For univariate comparisons, patients were stratified by BMI ≥ 30 kg/m 2 (obese) and < 30 kg/m 2 (nonobese). Baseline, 3-mo, and 12-mo follow-up parameters were collected. PROs included the North American Spine Society satisfaction questionnaire, numeric rating scale (NRS) back pain, NRS leg pain, Oswestry Disability Index (ODI), and EuroQoL-5D (EQ-5D) Questionnaire. RESULTS We identified 382 obese (47.9%) and 415 nonobese patients (52.1%). At baseline, obese patients had worse NRS back pain, NRS leg pain, ODI, and EQ-5D scores ( P < .001, P = .01, P < .001, and P = .02, respectively). Both cohorts improved significantly for back and leg pain, ODI, and EQ-5D at 12 mo ( P < .001). At 12 mo, similar proportions of obese and nonobese patients responded that surgery met their expectations (62.6% vs 67.4%, P = .24). In multivariate analyses, BMI was independently associated with worse NRS leg pain and EQ-5D at 12 mo ( P = .01 and P < .01, respectively) despite adjusting for baseline differences. CONCLUSION Obesity is associated with inferior leg pain and quality of life—but similar back pain, disability, and satisfaction—12 mo postoperatively. However, obese patients achieve significant improvements in all PRO metrics at 12 mo.
T4 extension alone is more predictive of better survival than a tumour size >7 cm for resected T4N0–1M0 non-small-cell lung cancer†
Li, Qiuyuan , Zhang, Peng , Luo, Lei , Diasio, Robert B. , Jiang, Gening , Wang, Yi , Liu, Dan , Yang, Ping

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | November 5, 2018 | Volume: 55 | Issue: 4 | Pages: 682-690

10.1093/ejcts/ezy360 | PMID 30508081 Get It

Computational Advances in the Label-free Quantification of Cancer Proteomics Data
Tang, Jing , Fu, Jianbo , Wang, Yunxia , Li, Yi , Yang, Qingxia , Yao, Lixia , Xue, Weiwei , Zhu, Feng , Zhang, Yang

Mayo Clinic

Current Pharmaceutical Design | November 2, 2018 | Volume: 24 | Issue: 32 | Pages: 3842-3858

10.2174/1381612824666181102125638 | PMID 30387388 Get It

Background: Due to its ability to provide quantitative and dynamic information on tumor genesis and development by directly profiling protein expression, the proteomics has become intensely popular for characterizing the functional proteins driving the transformation of malignancy, tracing the large-scale protein alterations induced by anticancer drug, and discovering the innovative targets and first-in-class drugs for oncologic disorders. Objective: To quantify cancer proteomics data, the label-free quantification (LFQ) is frequently employed. However, low precision, poor reproducibility and inaccuracy of the LFQ of proteomics data have been recognized as the key “technical challenge” in the discovery of anticancer targets and drugs. In this paper, the recent advances and development in the computational perspective of LFQ in cancer proteomics were therefore systematically reviewed and analyzed. Methods: PubMed and Web of Science database were searched for label-free quantification approaches, cancer proteomics and computational advances. Results: First, a variety of popular acquisition techniques and state-of-the-art quantification tools are systematically discussed and critically assessed. Then, many processing approaches including transformation, normalization, filtering and imputation are subsequently discussed, and their impacts on improving LFQ performance of cancer proteomics are evaluated. Finally, the future direction for enhancing the computation-based quantification technique for cancer proteomics are also proposed. Conclusion: There is a dramatic increase in LFQ approaches in recent year, which significantly enhance the diversity of the possible quantification strategies for studying cancer proteomics.
Role and future of MRI in radiation oncology
Das, Indra J. , McGee, Kiaran P. , Tyagi, Neelam , Wang, Hesheng , Das, Indra J.

Mayo Clinic

The British Journal of Radiology | November 1, 2018 | Volume: 92 | Issue: 1094 | Pages: 20180505

10.1259/bjr.20180505 | PMID 30383454 Get It